Ghassen Cheniti

Ghassen Cheniti

Auto-generated profile, based on publicly available information

Ghassen Cheniti

CRCTB, U1045, INSERM, IHU Liryc, University of Bordeaux, Bordeaux, France; Service de Cardiologie-électrophysiologie et stimulation cardiaque, Hôpital Haut Lévêque, INSERM, U1045, CHU de Bordeaux, Bordeaux, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2018 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
FBFelix Bourier
Felix Bourier
JDJosselin Duchateau
Josselin Duchateau
KVKonstantinos Vlachos
Konstantinos Vlachos
ALAnna Lam
Anna Lam
CMClaire A. Martin
Claire A. Martin
PJPierre Jais
Pierre Jais

1 September 2019 in Heart Rhythm
Verified
Journal Article
Closed access
KVKonstantinos Vlachos
Konstantinos Vlachos
ADArnaud Denis
Arnaud Denis
MTMasateru Takigawa
Masateru Takigawa
TKTakeshi Kitamura
Takeshi Kitamura
CMClaire A. Martin
Claire A. Martin
NDNicolas Derval
Nicolas Derval

1 March 2018 in Heart Rhythm
Verified
Journal Article
Closed access
MTMasateru Takigawa
Masateru Takigawa
NDNicolas Derval
Nicolas Derval
AFAntonio Frontera
Antonio Frontera
RMRuairidh Martin
Ruairidh Martin
SYSeigo Yamashita
Seigo Yamashita
PJPierre Jais
Pierre Jais

1 August 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
PDF file
TKTsukasa Kamakura
Tsukasa Kamakura
NDNicolas Derval
Nicolas Derval
JDJosselin Duchateau
Josselin Duchateau
ADArnaud Denis
Arnaud Denis
TNTakashi Nakashima
Takashi Nakashima
TPThomas Pambrun
Thomas Pambrun
Background: Vein of Marshall (VOM) ethanol infusion is a relatively new therapeutic option for atrial tachyarrhythmias. We aimed to evaluate the feasibility, pitfalls, and complications associated with this procedure in a large cohort of patients. Methods: Successful ethanol infusion, VOM-related lesion extent, and serious complications were evaluated in 713 consecutive patients treated with VOM ethanol infusion. Results: While feasible in 88.9% of cases, VOM ethanol infusion failure mainly resulted from nonidentification (6.2%), noncannulation (1.5%), or ethanol infusion in the wrong vein (1.7%). The Vieussens valve was a helpful landmark and was visible in 63.2% of cases. Multivariable analysis identified previous coronary sinus ablation as the only predictor for nonidentification. The mean area of VOM-related endocardial scarring was 10.2±5.3 cm 2 . VOM dissection (10.7%), iodine leakage (3.0%), and VOM morphology without visible branches (3.0%) were associated with smaller VOM-related scarring (5.0±3.9, 6.6±3.5, and 4.7±2.3 cm 2 , with a P <0.0001, P <0.044, and P <0.0001, respectively). Ethanol infusion in a wrong vein was associated with less mitral line block (72.7% versus 95.8%, P =0.012). A total of 14 serious complications (2.0%) occurred: 7 tamponades, of which were 6 delayed and treated with pericardiocentesis (2 of these patients had per-procedural VOM perforation), 4 strokes, 1 anaphylactic shock, 1 atrioventricular block, and 1 left appendage isolation. Only 4 of these complications occurred during the procedure. Conclusions: Although limited by previous coronary sinus ablation, VOM ethanol infusion is a highly feasible treatment for atrial tachyarrhythmia, with a low rate of serious complications.

1 February 2018 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
TKTakeshi Kitamura
Takeshi Kitamura
RMRuairidh Martin
Ruairidh Martin
ADArnaud Denis
Arnaud Denis
MTMasateru Takigawa
Masateru Takigawa
ADAlexandre Duparc
Alexandre Duparc
NDNicolas Derval
Nicolas Derval
Background: Biatrial tachycardia (BiAT) is a rare form of atrial macroreentrant tachycardia, in which both atria form a critical part of the circuit. We aimed to identify the characteristics and precise circuits of single-loop macroreentrant BiATs. Methods and Results: We identified 8 patients (median age, 59.5 years old) with 9 BiATs in a cohort of 336 consecutive patients from 2 institutions who had undergone AT catheter ablation using an automatic ultrahigh-resolution mapping system. Seven of the 8 patients had a history of persistent AF ablation, including septal or anterior left atrium ablation before developing BiAT. One of the 8 patients had a history of an atrial septal patch closure with a massively enlarged right atrium. Nine ATs (median cycle length, 334 ms; median 12 561 points in the left atrium; 8814 points in the right atrium) were diagnosed as single-loop macroreentrant BiATs. We observed 3 types of BiAT (1) BiAT with a perimitral and peritricuspid reentrant circuit (n=3), (2) BiAT using the right atrium septum and a perimitral circuit (n=3), and (3) BiAT using only the left atrium and right atrium septum (n=3). Catheter ablation successfully terminated 8 of the 9 BiATs. Conclusions: All patients who developed BiAT had an electric obstacle on the anteroseptal left atrium, primarily from prior ablation lesions. In this situation, mapping of both atria should be considered during AT. Because 3 types of single-loop BiAT were observed, ablation strategies should be adjusted to the type of BiAT circuit.

1 October 2018 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
RMRuairidh Martin
Ruairidh Martin
PMPhilippe Maury
Philippe Maury
CBCaterina Bisceglia
Caterina Bisceglia
TWTom Wong
Tom Wong
HEHeidi Estner
Heidi Estner
FSFrédéric Sacher
Frédéric Sacher
Background: Ventricular tachycardia (VT) with structural heart disease is dependent on reentry within scar regions. We set out to assess the VT circuit in greater detail than has hitherto been possible, using ultra-high-density mapping. Methods: All ultra-high-density mapping guided VT ablation cases from 6 high-volume European centers were assessed. Maps were analyzed offline to generate activation maps of tachycardia circuits. Topography, conduction velocity, and voltage of the VT circuit were analyzed in complete maps. Results: Thirty-six tachycardias in 31 patients were identified, 29 male and 27 ischemic. VT circuits and isthmuses were complex, 11 were single loop and 25 double loop; 3 had 2 entrances, 5 had 2 exits, and 15 had dead ends of activation. Isthmuses were defined by barriers, which included anatomic obstacles, lines of complete block, and slow conduction (in 27/36 isthmuses). Median conduction velocity was 0.08 m/s in entrance zones, 0.29 m/s in isthmus regions ( P <0.001), and 0.11 m/s in exit regions ( P =0.002). Median local voltage in the isthmus was 0.12 mV during tachycardia and 0.06 mV in paced/sinus rhythm. Two circuits were identifiable in 5 patients. The median timing of activation was 16% of diastole in entrances, 47% in the mid isthmus, and 77% in exits. Conclusions: VT circuits identified were complex, some of them having multiple entrances, exits, and dead ends. The barriers to conduction in the isthmus seem to be partly functional in 75% of circuits. Conduction velocity in the VT isthmus slowed at isthmus entrances and exits when compared with the mid isthmus. Isthmus voltage is often higher in VT than in sinus or paced rhythms.